UBS Group’s Parexel International PRXL Stock Holding History
Bought
Maintained
Sold
Other funds holding PRXL
UBS Group's PRXL Position: Q4 2017 in Review
UBS Group sold out of Parexel International (PRXL) in Q4 2017, closing a stake of 537,867 shares — an estimated $47.4M sold.
UBS Group first reported a position in PRXL in Q4 2014 and held it in 12 quarters. The position peaked at $218M in Q3 2016. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.
- UBS Group reported no remaining Parexel International position as of Q4 2017 after selling out during the quarter.
- UBS Group sold 537,867 Parexel International shares in Q4 2017, an estimated $47.4M.
- UBS Group first reported a position in Parexel International in Q4 2014 and held it in 12 quarters.
- UBS Group's Parexel International position peaked at $218M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Parexel International as of Q4 2017.
Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.